Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von StockNews.com 

Colgate-Palmolive Co. diskutieren

Colgate-Palmolive Co.

WKN: 850667 / Symbol: CL / Name: Colgate-Palmolive / Aktie / Persönl. & Haushaltsprodukte & -dienstleistungen / Large Cap /

66,93 €
1,10 %

Einschätzung Buy
Rendite (%) -14,95 %
Kursziel 102,84
Veränderung
Endet am 11.07.25

Colgate-Palmolive (NYSE: CL) had its price target raised by analysts at Citigroup Inc. from $103.00 to $112.00. They now have a "buy" rating on the stock.
Ratings data for CL provided by MarketBeat

Einschätzung Buy
Rendite (%) -15,92 %
Kursziel 96,50
Veränderung
Endet am 22.07.25

Colgate-Palmolive (NYSE: CL) had its price target raised by analysts at Stifel Nicolaus from $95.00 to $105.00. They now have a "buy" rating on the stock.
Ratings data for CL provided by MarketBeat

Einschätzung Buy
Rendite (%) -15,77 %
Kursziel 101,30
Veränderung
Endet am 23.07.25

Colgate-Palmolive (NYSE: CL) is now covered by analysts at TD Cowen. They set a "buy" rating and a $110.00 price target on the stock.
Ratings data for CL provided by MarketBeat

Einschätzung Buy
Rendite (%) -19,68 %
Kursziel 102,53
Veränderung
Endet am 29.07.25

Colgate-Palmolive (NYSE: CL) had its price target raised by analysts at Morgan Stanley from $103.00 to $111.00. They now have an "overweight" rating on the stock.
Ratings data for CL provided by MarketBeat

Einschätzung Buy
Rendite (%) -19,68 %
Kursziel 98,84
Veränderung
Endet am 29.07.25

Colgate-Palmolive (NYSE: CL) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $104.00 to $107.00. They now have a "buy" rating on the stock.
Ratings data for CL provided by MarketBeat

Einschätzung Buy
Rendite (%) -18,72 %
Kursziel 106,29
Veränderung
Endet am 30.07.25

Colgate-Palmolive (NYSE: CL) had its price target raised by analysts at TD Cowen from $110.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for CL provided by MarketBeat

Einschätzung Buy
Rendite (%) 4,37 %
Kursziel 98,50
Veränderung
Endet am 19.08.25

Hey there! I've been keeping an eye on Colgate-Palmolive, and I've got to say, I'm feeling pretty bullish about this stock. Why, you ask? Well, let's dive in! First off, CL has been a steady Eddie, showing consistent growth over the years. In fact, if you'd invested in CL five years ago, you'd be sitting on a sweet 58% gain right now. Not too shabby, right? But here's the kicker - CL isn't just about past performance. They've got some serious staying power. Think about it - when was the last time you went to the store and didn't see Colgate toothpaste or Palmolive dish soap? These guys are like the background music of our daily lives - always there, always reliable. Now, I know what you're thinking - 'But what about the economic uncertainty?' Well, here's the thing: CL is what we call a defensive stock. When the economy gets a bit wobbly, people might cut back on luxury items, but they're still gonna brush their teeth and wash their dishes. It's like CL has built itself a cozy little fortress in the consumer staples sector. Plus, have you seen their dividend game? It's strong, my friend. They've been consistently rewarding shareholders, which is like getting a cherry on top of your already delicious investment sundae. Sure, there are always risks - global economic slowdowns, rising costs, that sort of thing. But CL has weathered storms before, and they've got the brand power and market position to keep on trucking. So, while I can't tell you to buy or sell (that's your call, after all), I'm personally feeling pretty good about CL. With its current price around $92.7, I think there's room for growth. I'm eyeing a target price of $98.5 in the near future. Remember, though - investing is a bit like surfing. You've got to read the waves and make your own decisions. But from where I'm standing, CL looks like it could be a pretty sweet ride!

Einschätzung Buy
Rendite (%) -26,71 %
Kursziel 110,11
Veränderung
Endet am 04.09.25

Colgate-Palmolive (NYSE: CL) had its price target raised by analysts at UBS Group AG from $119.00 to $122.00. They now have a "buy" rating on the stock.
Ratings data for CL provided by MarketBeat

Einschätzung Sell
Rendite (%) -26,59 %
Kursziel 89,86
Veränderung
Endet am 16.09.25

Colgate-Palmolive (NYSE: CL) was downgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "underweight" rating. They now have a $100.00 price target on the stock.
Ratings data for CL provided by MarketBeat

Einschätzung Buy
Rendite (%) -26,00 %
Kursziel 108,57
Veränderung
Endet am 24.09.25

Colgate-Palmolive (NYSE: CL) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $121.00 price target on the stock.
Ratings data for CL provided by MarketBeat

Einschätzung Buy
Rendite (%) -25,54 %
Kursziel 104,20
Veränderung
Endet am 11.10.25

Colgate-Palmolive (NYSE: CL) had its price target raised by analysts at JPMorgan Chase & Co. from $113.00 to $114.00. They now have an "overweight" rating on the stock.
Ratings data for CL provided by MarketBeat

Einschätzung Buy
Rendite (%) -3,34 %
Kursziel 98,50
Veränderung
Endet am 24.10.25

Hey there, fellow investor! I've been keeping a close eye on Colgate-Palmolive, and I've got to say, I'm pretty excited about its prospects. Sure, the company's facing some headwinds with shifting consumer behaviors and inflation, but who isn't these days? What's really caught my attention is their impressive 38% return on capital employed. That's like hitting a home run in the consumer staples league! Now, I know some folks are worried about slowing growth rates, but let's not forget that Colgate-Palmolive is a rock-solid company with a global presence. They're not just resting on their laurels either - they're actively working on transforming their business model to focus on volume and mix growth. It's like they're teaching an old dog new tricks, and I'm here for it! With earnings expected to grow and a positive earnings surprise potentially on the horizon, I think there's some real upside potential here. The recent UBS report suggests there might be some mixed sentiment, but isn't that when the best opportunities often arise? It's like finding a diamond in the rough. So, while I can't tell you to buy or sell (that's your call!), I'm personally leaning towards the buy side. The target price of 98.50 reflects my optimism about their ability to navigate current challenges and come out stronger. Remember, in the world of investing, sometimes slow and steady wins the race - and Colgate-Palmolive seems to be running a smart marathon, not a sprint.

Einschätzung Buy
Rendite (%) -19,02 %
Kursziel 91,26
Veränderung
Endet am 14.03.26

Colgate-Palmolive (NYSE: CL) had its price target raised by analysts at JPMorgan Chase & Co. from $97.00 to $99.00. They now have an "overweight" rating on the stock.
Ratings data for CL provided by MarketBeat

Einschätzung Buy
Rendite (%) -21,77 %
Kursziel 98,70
Veränderung
Endet am 31.03.26

Colgate-Palmolive (NYSE: CL) had its price target lowered by analysts at Piper Sandler from $108.00 to $107.00. They now have an "overweight" rating on the stock.
Ratings data for CL provided by MarketBeat

Einschätzung Sell
Rendite (%) -22,23 %
Kursziel 81,54
Veränderung
Endet am 02.04.26

Colgate-Palmolive (NYSE: CL) had its price target raised by analysts at Wells Fargo & Company from $83.00 to $88.00. They now have an "underweight" rating on the stock.
Ratings data for CL provided by MarketBeat

Einschätzung Buy
Rendite (%) -4,16 %
Kursziel 92,50
Veränderung
Endet am 04.04.26

Hey there, fellow investor! I've been diving into Colgate-Palmolive's stock lately, and I gotta say, I'm feeling pretty bullish. You know how we all need toothpaste and soap, right? Well, Colgate's got us covered, and that's not changing anytime soon. With the current price at $86.5, I think there's room for growth. Sure, the market's been a bit of a rollercoaster lately, but Colgate's like that steady friend who's always there for you. Plus, have you seen the news about oil production? While that might not directly impact Colgate, it could affect overall market sentiment. But here's the thing - people will keep brushing their teeth and washing their hands no matter what happens with oil prices. So, I'm thinking Colgate might be a safe harbor in choppy waters. What do you reckon? Could be worth adding a tube... I mean, a few shares to your portfolio!

Colgate-Palmolive (NYSE: CL) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for CL provided by MarketBeat

Einschätzung Buy
Rendite (%) -19,18 %
Kursziel 84,22
Veränderung
Endet am 11.04.26

Colgate-Palmolive (NYSE: CL) had its price target lowered by analysts at JPMorgan Chase & Co. from $99.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for CL provided by MarketBeat

Einschätzung Buy
Rendite (%) -0,92 %
Kursziel 90,50
Veränderung
Endet am 12.04.26

Hey there! So, I've been looking into Colgate-Palmolive, and I've got to say, I'm feeling pretty positive about it. You know how we all need toothpaste and soap, right? Well, that's Colgate's bread and butter, and let's face it, people aren't going to stop brushing their teeth anytime soon! The company's got a solid reputation and a global presence that's hard to beat. Plus, with all this talk about OPEC+ and oil prices, Colgate's looking pretty stable in comparison. It's like a sturdy oak in a forest of swaying saplings. Sure, the current price of $82.88 might seem a bit high, but I think there's room for growth. My gut feeling? This stock could hit $90.50 in the near future. It's not going to make you rich overnight, but it could be a nice addition to your portfolio – kind of like adding a reliable family sedan to your garage full of sports cars.

Einschätzung Buy
Rendite (%) -20,16 %
Kursziel 95,92
Veränderung
Endet am 17.04.26

Colgate-Palmolive (NYSE: CL) had its price target raised by analysts at UBS Group AG from $105.00 to $109.00. They now have a "buy" rating on the stock.
Ratings data for CL provided by MarketBeat